H3K9 methyltransferases and demethylases control lung tumor-propagating cells and lung cancer progression

S. P. Rowbotham, F. Li, A. F. M. Dost, S. M. Louie, B. P. Marsh, P. Pessina, C. R. Anbarasu, C. F. Brainson, S. J. Tuminello, A. Lieberman, S. Ryeom, T. M. Schlaeger, B. J. Aronow, H. Watanabe, K. K. Wong and C. F. Kim ()
Additional contact information
S. P. Rowbotham: Children’s Hospital Boston
F. Li: New York University Langone Medical Center
A. F. M. Dost: Children’s Hospital Boston
S. M. Louie: Children’s Hospital Boston
B. P. Marsh: Children’s Hospital Boston
P. Pessina: Children’s Hospital Boston
C. R. Anbarasu: Children’s Hospital Boston
C. F. Brainson: University of Kentucky
S. J. Tuminello: Icahn School of Medicine at Mount Sinai
A. Lieberman: Abramson Cancer Center
S. Ryeom: Abramson Cancer Center
T. M. Schlaeger: Children’s Hospital Boston
B. J. Aronow: University of Cincinnati College of Medicine
H. Watanabe: Icahn School of Medicine at Mount Sinai
K. K. Wong: New York University Langone Medical Center
C. F. Kim: Children’s Hospital Boston

Nature Communications, 2018, vol. 9, issue 1, 1-13

Abstract: Abstract Epigenetic regulators are attractive anticancer targets, but the promise of therapeutic strategies inhibiting some of these factors has not been proven in vivo or taken into account tumor cell heterogeneity. Here we show that the histone methyltransferase G9a, reported to be a therapeutic target in many cancers, is a suppressor of aggressive lung tumor-propagating cells (TPCs). Inhibition of G9a drives lung adenocarcinoma cells towards the TPC phenotype by de-repressing genes which regulate the extracellular matrix. Depletion of G9a during tumorigenesis enriches tumors in TPCs and accelerates disease progression metastasis. Depleting histone demethylases represses G9a-regulated genes and TPC phenotypes. Demethylase inhibition impairs lung adenocarcinoma progression in vivo. Therefore, inhibition of G9a is dangerous in certain cancer contexts, and targeting the histone demethylases is a more suitable approach for lung cancer treatment. Understanding cellular context and specific tumor populations is critical when targeting epigenetic regulators in cancer for future therapeutic development.

Date: 2018
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-018-07077-1 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:9:y:2018:i:1:d:10.1038_s41467-018-07077-1

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-018-07077-1

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().